|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
30
|
|
pubmed:dateCreated |
2007-10-19
|
|
pubmed:abstractText |
Our goals were to evaluate the safety of adding rituximab to methotrexate (MTX)-based chemotherapy for primary CNS lymphoma, determine whether additional cycles of induction chemotherapy improve the complete response (CR) rate, and examine effectiveness and toxicity of reduced-dose whole-brain radiotherapy (WBRT) after CR.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4730-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17947720-Adult,
pubmed-meshheading:17947720-Aged,
pubmed-meshheading:17947720-Antibodies, Monoclonal,
pubmed-meshheading:17947720-Antibodies, Monoclonal, Murine-Derived,
pubmed-meshheading:17947720-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17947720-Central Nervous System Neoplasms,
pubmed-meshheading:17947720-Combined Modality Therapy,
pubmed-meshheading:17947720-Cranial Irradiation,
pubmed-meshheading:17947720-Cytarabine,
pubmed-meshheading:17947720-Female,
pubmed-meshheading:17947720-Humans,
pubmed-meshheading:17947720-Immunotherapy,
pubmed-meshheading:17947720-Lymphoma,
pubmed-meshheading:17947720-Male,
pubmed-meshheading:17947720-Methotrexate,
pubmed-meshheading:17947720-Middle Aged,
pubmed-meshheading:17947720-Procarbazine,
pubmed-meshheading:17947720-Prospective Studies,
pubmed-meshheading:17947720-Remission Induction,
pubmed-meshheading:17947720-Treatment Outcome,
pubmed-meshheading:17947720-Vincristine
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
|
|
pubmed:affiliation |
Memorial-Sloan Kettering Cancer Center, New York, NY 10021, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
